Group 6 Copy 79
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Chasing genes involved in the migration of bats

    Thousands of pregnant bats migrate 700 miles every year in search of quality food and roosts. They follow nectar...

    Florida Bay Wild Dolphin Research and Conservation Project

    Atlantic bottlenose dolphins (Tursiops truncatus) are a coastal species found throughout inshore waters in Florida...

    Backer Badge Funded

    A biology project funded by 47 people